Insider · CIK 0001120355
Timothy J Barberich
Files at TCRX (TScan Therapeutics, Inc.). First filing Dec 21, 2023, latest Dec 21, 2023.
In brief
Timothy J Barberich files SEC Form 4 as director at TCRX (TScan Therapeutics, Inc.). Since Dec 21, 2023, Timothy J Barberich has reported 1 open-market buy worth $142k and 0 open-market sells worth $0, the latest filed on Dec 21, 2023.
A track record needs three past buys with six months of prices behind them; Timothy J Barberich has 0, so none is measured yet.
The newest scored trade: bought $142k of TCRX on Dec 18, 2023, filed Dec 21, 2023, scored 52 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TCRX: TScan Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 52Moderate | TScan Therapeutics, Inc. | $142k 29,147 shares | +77% | +209% from low-32% from high |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 18, 2023 | TCRX TScan Therapeutics, Inc. | POpen-market purchase Voting Common Stock | +28,830 | $4.89 | $141k | 66,710 | Dec 21, 2023 |
| Dec 19, 2023 | TCRX TScan Therapeutics, Inc. | POpen-market purchase Voting Common Stock | +317 | $4.97 | $1,575 | 67,027 | Dec 21, 2023 |
Questions about Timothy J Barberich
Answered from the filings on this page, as of the latest one.
Is Timothy J Barberich buying or selling?
Not in the last 12 months. Timothy J Barberich's latest open-market trade on SEC Form 4 was bought $142k of TCRX on Dec 18, 2023.
How did Timothy J Barberich's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Timothy J Barberich has 0.
Where does Timothy J Barberich file Form 4?
Timothy J Barberich has filed Form 4 at TCRX (TScan Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.